Injective has launched onchain pre-IPO stocks for OpenAI, SpaceX, and Anthropic, making these previously gated private markets accessible to a broader audience. This move follows a trend in the crypto space, where platforms are enabling retail investors to trade private shares and gain synthetic price exposure without the traditional barriers of venture capital ties or lengthy capital lockups. Notably, Injective’s Helix app offers efficient on-chain trading with minimal fees, highlighting the platform’s role as a first mover in democratizing access to these pioneering assets.

OpenAI: OpenAI is a prominent artificial intelligence company developing advanced language models and generative AI technologies. It operates as a privately held entity with significant venture backing. The news highlights its pre-IPO stock now live for on-chain trading on Injective, enabling broader retail access.
SpaceX: SpaceX is an American aerospace manufacturer and space transportation company founded to revolutionize space technology through reusable rockets and commercial spaceflight. It remains privately held under Elon Musk’s leadership. Its pre-IPO shares are now available as on-chain stocks on Injective.
Anthropic: Anthropic is an AI research company focused on developing safe and reliable artificial general intelligence systems, including its Claude language models. It functions as a private enterprise emphasizing AI safety. The news features its pre-IPO stock launched on Injective for tokenized trading.
Injective: Injective is a purpose-built Layer 1 blockchain designed for high-performance decentralized finance and tokenized real-world assets, featuring an on-chain order book and cross-chain connectivity. It serves as infrastructure for financial applications including perpetual futures and spot trading. In the news, Injective has launched on-chain pre-IPO stocks for OpenAI, SpaceX, and Anthropic, positioning itself as a first mover in democratizing access to private markets.

Market Competition: OKX recently launched perpetual futures for OpenAI, SpaceX, and Anthropic pre-IPO trading, following Injective’s earlier rollout.
Product Innovation: Injective’s Helix app enables seamless on-chain trading of pre-IPO shares alongside US stocks and RWAs with sub-second execution and near-zero fees.
Accessibility Shift: Crypto platforms are providing synthetic price exposure to private companies without VC connections or lockup periods.